Pharmacists in Arlington, Massachusetts


30 Pharmacists found in Arlington
male pharmacist

Lawrence Anthony Maida


Pharmacist
121 Massachusetts Ave, Arlington, MA 02474
781-643-7840     781-643-0174

male pharmacist

Mr. Leo Francis Doherty, R.PH


Pharmacist
8 Gay St, Arlington, MA 02474
781-646-3827    

female pharmacist

Mrs. Lisa Jean Gray, RPH


Pharmacist
121 Massachussetts Ave, Arlington, MA 02474
781-643-7840     781-643-0174



female pharmacist

Lynn Vinh Diep, PHARMD


Pharmacist
833 Massachusetts Ave, Arlington, MA 02476
781-643-4272    

female pharmacist

Maryam Abdullah


Pharmacist
23 Mass Ave, Arlington, MA 02474
781-648-0557    

male pharmacist

Michael Hayes


Pharmacist
833 Mass Ave, Arlington, MA 02476
781-643-4272    

female pharmacist

Michelle Guaman, RPH


Pharmacist
1425 Massachusetts Ave, Arlington, MA 02476
781-646-3869    

female pharmacist

Ms. Petrece Marie Palmese, RPH


Pharmacist
1425 Massachusetts Ave, Arlington, MA 02476
781-646-3869    

male pharmacist

Riley Ray Arsenault


Pharmacist
833 Massachusetts Ave, Arlington, MA 02476
781-643-4272    

female pharmacist

Rupal Tushar Patel


Pharmacist
833 Mass Ave, Arlington, MA 02476
781-643-4272    

male pharmacist

Steve Jung


Pharmacist
833 Massachusetts Ave, Arlington, MA 02476
781-643-4272    

female pharmacist

Wainy Ngan


Pharmacist
833 Mass Ave, Arlington, MA 02476
781-643-4272    

female pharmacist

Wen Yi Hwang


Pharmacist
905 Massachusetts Ave, Arlington, MA 02476
781-643-3267     781-643-8572

male pharmacist

Zachary Edward Smith, PHARMD


Pharmacist
905 Massachusetts Ave, Arlington, MA 02476
781-643-8572    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.